Stability indicating method development and validation of ranolazine extended release tablets
Acta Pharmaceutica Sciencia, cilt.59, sa.3, ss.419-434, 2021 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 59 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.23893/1307-2080.aps.05925
- Dergi Adı: Acta Pharmaceutica Sciencia
- Derginin Tarandığı İndeksler: Scopus, EMBASE
- Sayfa Sayıları: ss.419-434
- Anahtar Kelimeler: Forced degradation, HPLC, Ranolazine, Stability indicating method, Validation
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi Adresli: Evet
Özet
© 2021, Istanbul Medipol University. All rights reserved.The objective of this study was to develop and validate the stability-indicating method for newly developed Extended-Release tablet formulation of Ranolazine. First, new Ranola-zine tablet formulation was developed. These tablets were analyzed by using a High-Per-formance Liquid Chromatography system with a UV detector at 220 nm wavelength and by using C8-3 column (150 mm x 4.6 mm i.d; 5 µm particle size). The injection volume of the system was 10 µl. The validation parameters; Selectivity, linearity, accuracy, robust-ness, precision and limit of quantification and detection parameters were proved good re-sults. A highly sensitive and simple HPLC-UV analytical method of the Ranolazine tablet formulation was developed in accordance with ICH Guideline Q2 and Q3.